View Cart (0 items)


Novartis to Buy Fougera Pharmaceuticals for $1.5 Billion

May 3, 2012
Novartis International has agreed to buy Fougera Pharmaceuticals, a maker of generic skin care medicine, for $1.525 billion in cash, reported by The New York Times. Under the terms of
Read More

Pfizer Q1 profit falls 19 percent

May 2, 2012
The Associated Press reports, Pfizer Inc. said Tuesday that its first-quarter profit fell 19 percent, mainly because new generic competition to its blockbuster cholesterol pill Lipitor cut U.S. sales by
Read More

Warner Chilcott to explore sale of company

May 1, 2012
Specialty pharmaceutical company Warner Chilcott Plc said it would explore strategic options, including preliminary talks with potential buyers, Reuters reports. The company said it hired Goldman Sachs as its financial
Read More

Bayer sues generic drug maker over erectile dysfunction drug

April 26, 2012
WILMINGTON, Del. — Bayer Pharma AG is suing generic drug maker Watson Pharmaceuticals Inc. for allegedly infringing two U.S. patents for the erectile dysfunction drug Staxyn, Bloomberg reported. Bayer
Read More

Pfizer to sell infant nutrition unit

April 19, 2012
NEW YORK — Pfizer Inc. has decided to sell its infant nutrition business as soon as next week, The New York Times reported. According to the story, Nestle appears
Read More

Idaho settles GlaxoSmithKline case for $2.6 million

April 18, 2012
BOISE, Idaho — Drugmaker GlaxoSmithKline has agreed to pay the state of Idaho $2.6 million to settle allegations that the company sold products at false or inflated prices, CNBC
Read More

J&J fined $1.1 billion in antipsychotic drug case

April 12, 2012
LITTLE ROCK, Ark. — An Arkansas judge ordered Johnson & Johnson to pay more than $1.1 billion in fines after a jury found the company’s officials misled doctors and
Read More

Pfizer cuts employee severance package to reduce costs

April 11, 2012
NEW YORK — Pfizer Inc. is cutting its employee severance package after May 14 in an effort to reduce costs, Bloomberg reported. The pharmaceutical giant, which has fired 26,000
Read More

U.S. pharmaceutical outsourcing shows post-recession gains

April 10, 2012
The upturn in the fortunes of pharmaceutical companies after the recession is mirrored by the U.S. contract manufacturing outsourcing (CMO) market, which is expected to grow at a compound
Read More

Blocked piping may have caused explosion at pharmaceutical plant

March 29, 2012
EDINBURGH, UK — Blocked piping may have caused a chemical alert at a pharmaceutical company in Edinburgh, BBC News reported. Emergency crews were called to reports of a small
Read More